Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E412574-5mg | 5mg | In stock | $195.90 | |
E412574-25mg | 25mg | In stock | $515.90 | |
E412574-100mg | 100mg | In stock | $1,033.90 | |
E412574-250mg | 250mg | In stock | $2,326.90 | |
E412574-1g | 1g | In stock | $8,375.90 | |
E412574-5g | 5g | In stock | $37,689.90 | |
E412574-25g | 25g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $169,601.90 |
SARS-CoV Inhibitors
Synonyms | N4-Hydroxycytidine | 3258-02-4 | EIDD-1931 | Beta-D-N4-hydroxycytidine | N(4)-Hydroxycytidine | Uridine, 4-oxime | N-hydroxycytidine | 4-N-Hydroxycytidine | EiDD1931 | C3D11PV2O4 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one | 1 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | EIDD-1931 (Beta-d-N4-hydroxycytidine, β-d-N4-hydroxycytidine, NHC) is an active metabolite of EIDD-2801, a promising COVID-19 inhibitor. EIDD-1931 (NHC) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic gro |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Product Description | Information EIDD-1931 EIDD-1931 (Beta-d-N4-hydroxycytidine, β-d-N4-hydroxycytidine, NHC) is an active metabolite of EIDD-2801, a promising COVID-19 inhibitor. EIDD-1931 (NHC) has broad spectrum antiviral activity against SARS-CoV-2 , MERS-CoV , SARS-CoV , and related zoonotic group 2b or 2c Bat-CoVs with average IC50 of 0.15 μM, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one |
---|---|
INCHI | InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 |
InChi Key | XCUAIINAJCDIPM-XVFCMESISA-N |
Canonical SMILES | C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O |
Isomeric SMILES | C1=CN(C(=O)N=C1NO)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O |
PubChem CID | 197020 |
Molecular Weight | 259.22 |
PubChem CID | 197020 |
---|---|
CAS Registry No. | 3258-02-4 |
ChEMBL Ligand | CHEMBL2178720 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I2307212 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307213 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307214 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307215 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307216 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307217 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307218 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307219 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307220 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307221 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307245 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307246 | Certificate of Analysis | Aug 25, 2023 | E412574 |
I2307327 | Certificate of Analysis | Aug 25, 2023 | E412574 |
Solubility | Solubility (25°C) In vitro Water: 15 mg/mL (57.86 mM); Ethanol: 3 mg/mL (11.57 mM); |
---|---|
Sensitivity | Air sensitive;Moisture sensitive;Heat sensitive |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
1. Chan CL, Jones RL, Lau HY. (1988) Bombesin-like peptides in health and disease. Proceedings of an international symposium. October 13-16, 1987, Rome, Italy. A tribute to Vittorio Erspamer, M.D.. Ann NY Acad Sci, 547 (3): (1-541). [PMID:3071214] |